Theracryf Plc (FRA:8EV)
Germany
· Delayed Price · Currency is EUR 0.0005
0.00 (0.00%)
At close: Dec 5, 2025
Theracryf Income Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | - | - | 0.4 | 0.44 | - | 0.19 | Upgrade
|
| Revenue Growth (YoY) | - | - | -10.41% | - | - | - | Upgrade
|
| Cost of Revenue | 2.23 | 2.11 | 3.95 | 5.53 | 3.18 | 3.39 | Upgrade
|
| Gross Profit | -2.23 | -2.11 | -3.55 | -5.09 | -3.18 | -3.2 | Upgrade
|
| Selling, General & Admin | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Operating Expenses | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Operating Income | -2.25 | -2.12 | -3.57 | -5.1 | -3.19 | -3.21 | Upgrade
|
| Interest & Investment Income | 0.06 | 0.01 | - | 0.1 | 0.02 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.03 | 0.03 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -2.15 | -2.09 | -3.57 | -5.01 | -3.17 | -3.21 | Upgrade
|
| Pretax Income | -2.15 | -2.09 | -3.57 | -5.01 | -3.17 | -3.21 | Upgrade
|
| Income Tax Expense | -0.14 | -0.14 | -0.43 | -0.96 | -0.44 | -0.54 | Upgrade
|
| Net Income | -2.01 | -1.94 | -3.14 | -4.04 | -2.73 | -2.67 | Upgrade
|
| Net Income to Common | -2.01 | -1.94 | -3.14 | -4.04 | -2.73 | -2.67 | Upgrade
|
| Shares Outstanding (Basic) | 1,399 | 538 | 275 | 275 | 275 | 147 | Upgrade
|
| Shares Outstanding (Diluted) | 1,399 | 538 | 275 | 275 | 275 | 147 | Upgrade
|
| Shares Change (YoY) | 300.38% | 95.83% | - | - | 86.97% | 13.69% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.02 | Upgrade
|
| Free Cash Flow | -1.7 | -2.37 | -3 | -4.13 | -2.59 | -2.93 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.02 | Upgrade
|
| Operating Margin | - | - | -900.51% | -1154.75% | - | -1656.19% | Upgrade
|
| Profit Margin | - | - | -792.17% | -914.71% | - | -1378.35% | Upgrade
|
| Free Cash Flow Margin | - | - | -756.57% | -933.94% | - | -1510.83% | Upgrade
|
| EBITDA | -2.21 | -2.06 | -3.55 | -5.09 | -3.18 | -3.2 | Upgrade
|
| D&A For EBITDA | 0.04 | 0.07 | 0.01 | 0.01 | 0.02 | 0.02 | Upgrade
|
| EBIT | -2.25 | -2.12 | -3.57 | -5.1 | -3.19 | -3.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.